Drugs

Tirzepatide, the first “twincretin,” reduces A1C and body weight in adults with type 2 diabetes.

Other changes include recommendations for de-escalation of dual antiplatelet therapy in select patients and dual antiplatelet therapy post-CABG.

A review of new launches, new indications, new dosage forms and Health Canada advisories.

A study examines if cessation of metformin therapy is associated with dementia incidence and whether changes in blood glucose or insulin use affect the findings.

All of the following statements about the use of Rinvoq (upadacitinib) in inflammatory bowel disease are true, EXCEPT for . . .

More than 30,000 U.S. mpox cases were reported last year.

It is the first oral Janus kinase (JAK) inhibitor indicated for acute treatment and maintenance therapy in both Crohn's disease and ulcerative colitis in adults.

If you are raising stopping or reducing a medication as an option, explain why this is being considered.